Prostatis Group LLC Abbott Laboratories Transaction History

Prostatis Group LLC

$215 Billion
Q2 2023

A detailed history of Prostatis Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Prostatis Group LLC holds 41,415 shares of ABT stock, worth $4.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

41,415

Holding current value

$4.8 Million

% of portfolio

0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $4.17 Million - $4.65 Million	41,415 New	41,415 $111 Million
Q4 2022 Mar 23, 2023	SELL	$95.06 - $111.52 $65.2 Million - $76.5 Million	-685,832 Reduced 90.0%	76,176 $147 Million
Q3 2022 Mar 28, 2023	SELL	$96.76 - $112.03 $445,966 - $516,346	-4,609 Reduced 34.78%	8,641 $836 Million
Q3 2022 Mar 23, 2023	BUY	$96.76 - $112.03 $65.3 Million - $75.6 Million	674,983 Added 775.62%	762,008 $836 Million
Q2 2022 Mar 23, 2023	SELL	$102.07 - $123.37 $135 Million - $163 Million	-1,325,278 Reduced 93.84%	87,025 $157 Million
Q1 2022 Mar 28, 2023	BUY	$114.02 - $139.04 $25,654 - $31,284	225 Added 1.73%	13,250 $1.57 Billion
Q1 2022 Mar 23, 2023	SELL	$114.02 - $139.04 $33 Million - $40.3 Million	-289,487 Reduced 17.01%	1,412,303 $1.57 Billion
Q4 2021 Mar 28, 2023	BUY	$115.53 - $141.46 $273,459 - $334,835	2,367 Added 22.21%	13,025 $1.83 Billion
Q4 2021 Mar 23, 2023	BUY	$115.53 - $141.46 $52.3 Million - $64.1 Million	453,014 Added 36.28%	1,701,790 $1.83 Billion
Q3 2021 Mar 28, 2023	BUY	$116.66 - $129.06 $1.34 Million - $1.49 Million	11,509 New	11,509 $1.36 Billion
Q3 2021 Mar 23, 2023	BUY	$116.66 - $129.06 $14.3 Million - $15.8 Million	122,773 Added 10.9%	1,248,776 $1.36 Billion
Q2 2021 Mar 28, 2023	BUY	$105.79 - $124.53 $167,677 - $197,380	1,585 Added 17.47%	10,658 $1.24 Billion
Q2 2021 Mar 23, 2023	BUY	$105.79 - $124.53 $21.4 Million - $25.2 Million	202,723 Added 21.96%	1,126,003 $1.24 Billion
Q1 2021 Mar 28, 2023	SELL	$108.84 - $128.23 $7.3 Million - $8.6 Million	-67,103 Reduced 88.09%	9,073 $1.09 Billion
Q1 2021 Mar 23, 2023	BUY	$108.84 - $128.23 $96.8 Million - $114 Million	889,745 Added 2653.18%	923,280 $1.09 Billion
Q4 2020 Mar 23, 2023	SELL	$105.0 - $114.42 $4.4 Million - $4.79 Million	-41,878 Reduced 55.53%	33,535 $108 Million
Q3 2020 Mar 23, 2023	BUY	$91.64 - $111.29 $1.11 Million - $1.34 Million	12,063 Added 19.04%	75,413 $155 Million
Q2 2020 Mar 23, 2023	BUY	$76.57 - $98.0 $959,958 - $1.23 Million	12,537 Added 24.67%	63,350 $119 Million
Q1 2020 Mar 23, 2023	SELL	$62.82 - $91.86 $44,727 - $65,404	-712 Reduced 1.38%	50,813 $103 Million
Q4 2019 Mar 23, 2023	BUY	$78.51 - $87.4 $4.05 Million - $4.5 Million	51,525 New	51,525 $104 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Account

Prostatis Group LLC Abbott Laboratories Transaction History